NO20021634L - Fremstilling av rekombinante adenoviruser og adenovirusbanker - Google Patents

Fremstilling av rekombinante adenoviruser og adenovirusbanker

Info

Publication number
NO20021634L
NO20021634L NO20021634A NO20021634A NO20021634L NO 20021634 L NO20021634 L NO 20021634L NO 20021634 A NO20021634 A NO 20021634A NO 20021634 A NO20021634 A NO 20021634A NO 20021634 L NO20021634 L NO 20021634L
Authority
NO
Norway
Prior art keywords
banks
adenovirus
preparation
recombinant adenoviruses
adenoviruses
Prior art date
Application number
NO20021634A
Other languages
English (en)
Other versions
NO330916B1 (no
NO20021634D0 (no
Inventor
Jean-Jacques Robert
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20021634D0 publication Critical patent/NO20021634D0/no
Publication of NO20021634L publication Critical patent/NO20021634L/no
Publication of NO330916B1 publication Critical patent/NO330916B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20021634A 1999-10-07 2002-04-05 Fremstilling av rekombinante adenovirus og et kit som inneholder plasmider med avkortede adenovirusgenom. NO330916B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9912521A FR2799472B1 (fr) 1999-10-07 1999-10-07 Preparation d'adenovirus recombinants et de banques adenovirales
US16835699P 1999-12-01 1999-12-01
PCT/FR2000/002774 WO2001025463A1 (fr) 1999-10-07 2000-10-05 Preparation d'adenovirus recombinants et de banques adenovirales

Publications (3)

Publication Number Publication Date
NO20021634D0 NO20021634D0 (no) 2002-04-05
NO20021634L true NO20021634L (no) 2002-06-04
NO330916B1 NO330916B1 (no) 2011-08-15

Family

ID=26235132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021634A NO330916B1 (no) 1999-10-07 2002-04-05 Fremstilling av rekombinante adenovirus og et kit som inneholder plasmider med avkortede adenovirusgenom.

Country Status (22)

Country Link
US (1) US8263395B2 (no)
EP (1) EP1224310B1 (no)
JP (1) JP5260815B2 (no)
KR (1) KR100928105B1 (no)
CN (1) CN1384885B (no)
AT (1) ATE355385T1 (no)
AU (1) AU785431B2 (no)
BR (1) BR0014489B1 (no)
CA (1) CA2383225C (no)
CZ (1) CZ302282B6 (no)
DE (1) DE60033679T2 (no)
DK (1) DK1224310T3 (no)
FR (1) FR2799472B1 (no)
HK (1) HK1050211B (no)
HU (1) HU228933B1 (no)
IL (2) IL148493A0 (no)
MX (1) MXPA02003247A (no)
NO (1) NO330916B1 (no)
NZ (1) NZ518763A (no)
PL (1) PL210590B1 (no)
WO (1) WO2001025463A1 (no)
ZA (1) ZA200202481B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001059071A2 (en) * 2000-02-09 2001-08-16 Genvec, Inc. Methods of preparing and using a viral vector library
EP2471909A1 (en) * 2010-12-30 2012-07-04 SIRION BIOTECH GmbH Nucleic acid molecules for generating adenoviral vectors
GB201322851D0 (en) * 2013-12-23 2014-02-12 Psioxus Therapeutics Ltd Method
CN109576231B (zh) 2017-09-28 2022-03-25 北京康万达医药科技有限公司 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途
US11845952B2 (en) 2018-02-07 2023-12-19 Nippon Medical School Foundation Adeno-associated virus vector

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486053T3 (de) 1983-10-20 2004-01-08 The Research Foundation Of State University Of New York Regulierung von Gen-Expression durch Translationshemmung unter Verwendung von m-RNS hinderndem Komplementär-RNS.
FR2573436B1 (fr) 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US6696420B1 (en) * 1984-11-20 2004-02-24 Institut Pasteur Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
FR2602790B1 (fr) 1986-08-13 1990-06-01 Transgene Sa Expression d'un antigene specifique de tumeur par un virus vecteur recombinant et utilisation de celui-ci pour le traitement preventif ou curatif de la tumeur correspondante
US5744133A (en) * 1986-08-13 1998-04-28 Transgene S.A. Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor
US6007806A (en) * 1986-08-13 1999-12-28 Transgene S.A. Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
JPH08503855A (ja) 1992-12-03 1996-04-30 ジェンザイム・コーポレイション 嚢胞性線維症に対する遺伝子治療
FR2704556B1 (fr) 1993-04-30 1995-07-13 Rhone Poulenc Rorer Sa Virus recombinants et leur utilisation en thérapie génique.
FR2705363B1 (fr) 1993-05-13 1995-08-11 Clecim Sa Procédé de fusion de ferraille dans un four électrique et installation pour la mise en Óoeuvre du procédé.
FR2705361B1 (fr) 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
US6133028A (en) * 1993-05-28 2000-10-17 Transgene S.A. Defective adenoviruses and corresponding complementation lines
KR100356615B1 (ko) 1993-07-13 2003-04-03 아방티 파르마 소시에테 아노님 결함아데노바이러스벡터및유전자치료에서그의사용
FR2718150B1 (fr) * 1994-03-29 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
US7252989B1 (en) 1994-04-04 2007-08-07 Board Of Regents, The University Of Texas System Adenovirus supervector system
ATE336587T1 (de) 1994-06-10 2006-09-15 Genvec Inc Adenoviren-vektor systeme und zelllinien
FR2724945B1 (fr) 1994-09-27 1996-12-27 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
FR2726285B1 (fr) 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
FR2730504B1 (fr) * 1995-02-13 1997-03-28 Rhone Poulenc Rorer Sa Procede de preparation de genomes d'adenovirus recombinants
FR2730411B1 (fr) * 1995-02-14 1997-03-28 Centre Nat Rech Scient Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes
NZ312332A (en) * 1995-06-07 2000-01-28 Life Technologies Inc Recombinational cloning using engineered recombination sites
US5783431A (en) * 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
FR2749857B1 (fr) 1996-06-12 1998-08-14 Centre Nat Rech Scient Generation de molecules replicatives in vivo
FR2755975B1 (fr) * 1996-11-15 1999-05-07 Rhone Poulenc Rorer Sa Virus recombinants bicistroniques utiles pour le traitement de pathologies liees aux dyslipoproteinemies
US5846812A (en) * 1996-11-22 1998-12-08 Pioneer Hi-Bred International, Inc. Zearalenone detoxification compositions and methods
FR2774699B1 (fr) * 1997-11-17 2003-10-03 Rhone Poulenc Rorer Sa Methode de reduction des evenements de recombinaison homologue
US5922576A (en) * 1998-02-27 1999-07-13 The John Hopkins University Simplified system for generating recombinant adenoviruses
US6844270B2 (en) * 2000-11-26 2005-01-18 Shipley Company, L.L.C. Polymers and photoresist compositions for short wavelength imaging
SE523617C2 (sv) * 2001-10-01 2004-05-04 Sandvik Ab Skär för spånavskiljande bearbetning försedd med spånbrytande geometri
JP4308485B2 (ja) * 2002-07-08 2009-08-05 パナソニック株式会社 容量素子の製造方法
US6856551B2 (en) * 2003-02-06 2005-02-15 Sandisk Corporation System and method for programming cells in non-volatile integrated memory devices

Also Published As

Publication number Publication date
AU7794700A (en) 2001-05-10
CZ20021215A3 (cs) 2002-08-14
HU228933B1 (en) 2013-06-28
NZ518763A (en) 2005-01-28
IL148493A (en) 2010-04-15
JP5260815B2 (ja) 2013-08-14
HK1050211B (zh) 2008-01-25
CN1384885A (zh) 2002-12-11
BR0014489A (pt) 2002-06-04
EP1224310A1 (fr) 2002-07-24
FR2799472B1 (fr) 2004-07-16
US8263395B2 (en) 2012-09-11
ATE355385T1 (de) 2006-03-15
NO330916B1 (no) 2011-08-15
HUP0203801A3 (en) 2005-01-28
HK1050211A1 (en) 2003-06-13
CZ302282B6 (cs) 2011-02-02
HUP0203801A2 (hu) 2003-03-28
FR2799472A1 (fr) 2001-04-13
DK1224310T3 (da) 2007-07-02
CN1384885B (zh) 2011-06-22
KR100928105B1 (ko) 2009-11-24
NO20021634D0 (no) 2002-04-05
PL354099A1 (en) 2003-12-29
US20090149349A1 (en) 2009-06-11
AU785431B2 (en) 2007-05-31
JP2003512823A (ja) 2003-04-08
EP1224310B1 (fr) 2007-02-28
DE60033679T2 (de) 2007-11-15
MXPA02003247A (es) 2002-09-30
KR20020057969A (ko) 2002-07-12
ZA200202481B (en) 2003-09-23
IL148493A0 (en) 2002-09-12
DE60033679D1 (de) 2007-04-12
WO2001025463A1 (fr) 2001-04-12
CA2383225A1 (fr) 2001-04-12
CA2383225C (fr) 2011-12-13
PL210590B1 (pl) 2012-02-29
BR0014489B1 (pt) 2013-05-21

Similar Documents

Publication Publication Date Title
IL132951A0 (en) Compounds preparation and use for transferring nucleic acids into cells
WO2001023597A3 (en) Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
NO962791L (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
EP1650307A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
HRP20120132A8 (hr) Azabicikloalkani u svojstvu modulatora ccr5
ATE540686T1 (de) Adenovirus mit erhöhter infektiosität und konditionaler replikationsfähigkeit und deren verwendungen
AU2001292995A1 (en) Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction
WO1998013499A3 (en) Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
WO2004099422A3 (en) Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
WO1999032516A3 (en) Pharmaceutical compositions containing the long pentraxin ptx3
WO2001004282A3 (en) Replication-competent anti-cancer vectors
WO2000042208A8 (en) Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
WO1999046371A3 (en) Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery
NO20021634L (no) Fremstilling av rekombinante adenoviruser og adenovirusbanker
DK0843731T3 (da) Adenovirusvektorer til genterapi
MXPA05004074A (es) Nuevos adenovirus, acidos nucleicos que los codifican y su uso.
FR2778670B1 (fr) Methodes et compositions pour la production de particules virales
CA2441535A1 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
AU3880900A (en) Surface localized colligin/hsp47 in carcinoma cells
WO2000004918A3 (de) Mittel zur immuntherapie von tumorerkrankungen
ATE359372T1 (de) Vektoren zur inhibierung von viralem und tumorwachstum
MXPA03003983A (es) Formulaciones que comprenden polimeros de dextrina en combinacion con azucares para la administracion de acidos nucleicos.
HK1040532A1 (zh) 多能性細胞-1
AU2000265672A1 (en) Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees